Accessibility
Contact
Latest News
News
Key Takeaways from ARVO and ASGCT 2026
Recent presentations at ARVO and ASGCT highlighted several important developments in the treatment landscape for geographic atrophy (GA) and inherited …
10th June 2026
Press Release
Ikarovec to Advance Pipeline with Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression …
6th January 2026
News
Ikarovec to Present at LSX Investival Showcase During London Life Sciences Week
CSO Katie Binley, PhD to showcase dual-pathway gene therapy approach for Geographic Atrophy Norwich, UK – [Date] – Ikarovec Limited …
5th November 2025
News
FDA Provides Positive Feedback on IKAR-001 Development Plan
Ikarovec s advancing IKAR-001 with regulatory guidance supporting dual-pathway gene therapy approach Norwich, UK – [Date] – Ikarovec Limited today …
27th October 2025
News
Ikarovec Advances Series A Fundraising with Strong Momentum
Company releases updated corporate deck highlighting preclinical superiority, regulatory progress, and compelling investment opportunity Norwich, UK – 22/10/2025 – Ikarovec …
22nd October 2025
Press Release
New Scientific Advisory Board of world leaders in retinal research and clinical care joins Ikarovec
International experts to help drive company success as it launches its Series A fundraising Norwich, UK, September 30 2025 – …
30th September 2025
Press Release
Preclinical data highlights potential of Ikarovec’s bicistronic gene therapy approach in common causes of vision loss
Posted on 28th May 2025 by ikarovec Norwich, UK, May 28 2025 – Ikarovec, a leader in ophthalmology innovation with a sophisticated field-changing …
28th May 2025
Press Release
Ikarovec appoints Thomas Ciulla MD MBA, expert in ophthalmology drug development, as President and CEO
Posted on 6th May 2025 by ikarovec Spark Therapeutics veteran brings over 25 years’ of leadership experience to drive translation of company’s …
6th May 2025
Press Release
Ikarovec’s seed round extension brings total to £8M with proceeds to advance lead sight loss programme towards clinic
Ikarovec, which is developing novel bicistronic gene therapies for major chronic eye diseases, is pleased to announce that it has…
23rd October 2024
Events
Where to meet us
Conference
The Ikarovec team will be attending ESGCT
Hamburg, Germany
October 27 – 30th, 2026
Conference
The Ikarovec team will be attending EURetina
Vienna, Austria
October 1 – 4th, 2026
Conference
The Ikarovec Team attended BioEurope
Lisbon, Portugal
May 23-25th, 2026
Conference
The Ikarovec Team attended ASGCT
Boston, US
May 11-15th, 2026
Past events
